Rosarie lynch, EPA, HSE and ESRI, Environment, Health and Wellbeing Conference 2020

The document summarizes progress made under Ireland's National Action Plan on Antimicrobial Resistance 2017-2020 (iNAP 1) and outlines plans for iNAP 2. It discusses successes in areas like surveillance, guidelines and awareness campaigns. It also notes challenges from COVID-19, which led to delays in developing iNAP 2. Resources have been substantially invested in 2018-2021 to support iNAP 1 goals and respond to COVID-19, including new IPC staff across healthcare settings. Stakeholder engagement for iNAP 2 will begin following scoping of ongoing activities and lessons from COVID-19.